LAG-3 has been described as an essential next-generation immune checkpoint receptor proposed as a therapeutic target against cancer, autoimmune and inflammatory diseases, parasitic infections, and acute and chronic viral infections [10,118,119,120,121]. The gene discussed is LAG3; the disease is cancer.